IFNA17 and cancer: They found the motion trajectory of the DCs in the 3D space was driven toward the cancers treated with an epigenetic drug romidepsin and INF-α (RI), but not toward those without treatment, and the RI treatment-driven DC migration was blocked by CXCR4 inhibition.